
Loading, please wait...

Loading, please wait...

A multidisciplinary Delphi study developed practical screening signals for pulmonary hypertension in patients with interstitial lung disease. The panel identified a combination of clinical symptoms and signs, CT and other imaging findings, oxygenation measures, BNP or NT-proBNP, and changes in pulmonary function or six-minute walk performance as useful triggers for further evaluation. The value of the paper is its real-world orientation: pulmonary hypertension in ILD can be easy to miss because worsening dyspnoea and exercise limitation may be attributed entirely to parenchymal lung disease. The consensus approach helps clinicians recognize when the clinical trajectory is disproportionate and should prompt focused assessment. For HCPs, the message is not that every patient needs routine invasive testing. Rather, a structured screening pathway can identify patients who warrant echocardiography and, when indicated, right-heart catheterization or specialist referral. This aligns closely with the conference’s session on pulmonary hypertension screening in progressive ILD and with its broader emphasis on using trends over time to detect clinically important change.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A multidisciplinary Delphi study developed practical screening signals for pulmonary hypertension in patients with interstitial lung disease. The panel identified a combination of clinical symptoms and signs, CT and other imaging findings, oxygenation measures, BNP or NT-proBNP, and changes in pulmonary function or six-minute walk performance as useful triggers for further evaluation. The value of the paper is its real-world orientation: pulmonary hypertension in ILD can be easy to miss because worsening dyspnoea and exercise limitation may be attributed entirely to parenchymal lung disease. The consensus approach helps clinicians recognize when the clinical trajectory is disproportionate and should prompt focused assessment. For HCPs, the message is not that every patient needs routine invasive testing. Rather, a structured screening pathway can identify patients who warrant echocardiography and, when indicated, right-heart catheterization or specialist referral. This aligns closely with the conference’s session on pulmonary hypertension screening in progressive ILD and with its broader emphasis on using trends over time to detect clinically important change.
4 weeks back

A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
4 days back

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back

Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
5 days back

A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back

Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back